WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 722
GDP / capita (US$): 2'7841 Child (under 5 years) mortality rate: 902

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 860  847  834  822  810  723  590  359 
Births 24  24  24  24  23  22  23  14 
Surviving infants 23  22  22  22  22  20  21  13 
Pop. less than 5 years 108  106  104  103  102  99  108  68 
Pop. less than 15 years 290  287  285  284  285  299  265  167 
Female 15-49 years 231  228  224  220  215  174  134  80 

Number of reported case

(Click for retrospective incidence data for Djibouti)
Diphtheria 411 
Japanese encephalitis
Measles 709  49  48  143  183  104 
Mumps
Pertussis 48  25 
Polio*
Rubella 15  118 
Rubella (CRS) 16 
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Djibouti)
Vaccine year result method % card seen                                                
BCG 2007  93  EPI     87  89  90  90  90  34  95 
DTP1 2007  91  EPI     85  89  90  90  90  66 
DTP3 2007  83  EPI     81  87  88  89  89  46  85 
HepB_BD          87 
HepB3 2007  83  EPI     87  88  89  88 
Hib3 2007  83  EPI     87  88  89  89 
JapEnc         
MCV 2007  73  EPI     83  84  85  84  73  50  85 
MCV2          82 
PCV1         
PCV3         
Pol3 2007  83  EPI     81  87  88  89  89  46  85 
Rota1         
Rota_last         
Rubella1         
TT2plus 1988  59  EPI   72.0  65  70  69  70  86  15  80 
PAB         
VAD1          85  85  85  90  12 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Djibouti)
BCG 87  89  90  90  90  34  81 
DTP1 85  89  90  90  90  66  95 
DTP3 81  87  88  89  89  46  85 
HepB3 81  87  88  89  88 
Hib3 81  87  88  89  89 
MCV 83  84  85  84  73  50  85 
PAB 79  79  79  77  79  46  80 
PCV3
Pol3 81  87  88  89  89  46  85 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 17
From 80 to 89% 17
From 50 to 79% 67
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 15 months; Yes
DTwPHibHepB 6, 10, 14 months;
HepB birth; Yes
Measles 9, 15 months; Yes
OPV birth; 6, 10, 14 weeks; 15 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus Yes From September 2013
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2010-2014  2010-2014  2008 - 2012  2008 - 2011  2002-2006. 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 33  83  67  67  67  17 
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%      

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes           

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 26  No     

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.